Hengrui Medicine | Briefing, News, Analysis, Research, Data

Hengrui Medicine

iangsu Hengrui Medicine develops, manufactures, and markets a variety of medicines and medicine packing materials.

Hengrui Medicine, founded in April, 1997 and headquartered in Lianyungang, is an innovative pharmaceutical developer. The founder is Zhou Yunshu. Listed on the SSE on October 18, 2000, the company's major shareholders are Jiangsu Hengrui Pharmaceutical Group Co., Ltd., Tibet Dayuan Enterprise Management Co., Ltd. and Hong Kong Securities Clearing Co., Ltd.. Rivals that have direct and indirect competition with Hengrui Medicine include Harbin Pharmaceutical, Yunnan Baiyao, Glaxo Smith Kline, Pfizer, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Generic Pharma

Founded

Apr 28, 1997

HQ location

Jiangsu, China

Legal name

Jiangsu Hengrui Medicine Co., Ltd.

Website

http://www.hrs.com.cn/

litianyu@hrs.com.cn

Employees

21016

All
News
Analysis
Research

Briefing May 27, 2022 06:18 PM · Healthcare | Real Estate

Declaration of the first affordable rental housing REITs

Briefing May 25, 2022 04:59 PM · Technology | Healthcare | Real Estate

Harbin housing and Urban Rural Development Bureau organized and held a working meeting on handling the risk of overdue delivery and uncompleted tail of Evergrande real estate project

In-depth

Half light, half shadow. Image credit: Fabio Rose/Unsplash

Healthcare

Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows

A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?

May 22, 2020 10:52 PM

Briefing May 23, 2022 06:54 PM · Technology | Healthcare

Linyang energy: the holding subsidiary won the bid for the 274 million yuan energy storage equipment procurement project

Briefing May 19, 2022 05:05 PM · Technology | Healthcare | Financials

Heavy Pharmaceutical Holdings: heavy Pharmaceutical Co., Ltd. plans to provide financial assistance of 57.72 million yuan to heavy pharmaceutical Jiulong

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Technology, Consumer Staples

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Briefing May 10, 2022 04:50 PM · Technology | Consumer Staples | Healthcare

Hengrui medicine: ω- 3. Fatty acid ethyl ester 90 soft capsule has obtained the drug registration certificate

Briefing Apr 27, 2022 05:05 PM · Technology | Consumer Staples | Healthcare

Four European gas buyers have bought gas in rubles.

Briefing Apr 25, 2022 06:25 PM · Healthcare

Yingkang life: it is expected to lose 300 million yuan to 370 million yuan in 2021

Briefing Apr 25, 2022 09:45 AM

The coal sector fell sharply at the opening, and Shanghai Energy fell by the limit

Healthcare

EqualOcean and Skepsos Sign Strategic Cooperation Memorandum of Understanding

On May 20, 2025, Beijing EO Technology Co.,Ltd and the Greater Paris Health Industry Park (Skepsos) officially signed a Memorandum of Understanding on Strategic Cooperation in Beijing.

May 23, 2025 09:21 PM

Healthcare

Beijing Pilots The DRG External Payment Mode

DRG refers to the diagnosis-related group used to classify the patient and set up a system to ensure the care provided is necessary. The National Healthcare Security Administration will pay the hospital a predetermined amount according to a patient’s DRG.

Jul 16, 2022 12:12 AM

Briefing Apr 22, 2022 07:35 PM · Technology | Consumer Discretionary | Healthcare

State Intellectual Property Office: crack down on "porcelain touch" rights protection and promote balanced protection

Briefing Apr 19, 2022 08:14 AM · Consumer Staples | Healthcare

361 degrees announced that the retail sales of main brand products in the first quarter recorded a high double-digit growth year-on-year.

Briefing Apr 01, 2022 05:04 PM · Technology | Consumer Staples | Healthcare

Heilongjiang Provincial Department of culture and Tourism: arrange at least 200 million funds to support the development of ice and snow industry every year

Healthcare

CSPC Pharma’s Arthritis Painkiller Listed by China's Medical Agency

CSPC Pharmaceutical has seized the chance of entry into the third national centralized procurement and expects stable sales for the generic drug Celecoxib.

Jul 13, 2020 06:48 PM

The stethoscope was taken out of the brown leather. Image credit: Marcelo Leal/Unsplash

Healthcare · Analysis

New Normal, New Policies: A Focus on Healthcare in Two Sessions

The week-long Chinese virtual ‘Two Sessions’ meeting closed on May 28. The hovering pandemic has made the healthcare topic a highlight for the 2020 third session of the 13th National People’s Congress.

Jun 03, 2020 03:06 PM

Briefing Mar 14, 2022 07:48 AM · Healthcare

Defining key tasks and accelerating the construction of new urbanization

Briefing Mar 09, 2022 04:58 PM · Healthcare | Industrials | Financials

Daodaoquan: Chongqing subsidiary plans to apply to the bank for a credit line of 160 million yuan

Briefing Feb 23, 2022 01:09 PM · Technology | Healthcare

The 14th five year development plan of Shenzhen national high tech Zone aims to reach 200 listed enterprises in the zone by 2025

Briefing Feb 16, 2022 04:39 PM · Consumer Staples | Healthcare | Financials

Industrial Securities: the duration of the employee stock ownership plan will expire on August 17

EqualOcean Analysis